APO Research
Talk to an analyst

APO RESEARCH · REPORT

Intraveno (IV) Iron Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Intraveno (IV) Iron Drugs Industry Growth and Trends Forecast to 2032

20 December 2025104 pages

Choose your research edition.

Industry ResearchIntraveno (IV) Iron Drugs Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Intraveno (IV) Iron Drugs Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Intraveno (IV) Iron Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Intraveno (IV) Iron Drugs Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Intraveno (IV) Iron Drugs Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Intraveno (IV) Iron Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Intraveno (IV) Iron Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Intraveno (IV) Iron Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Intraveno (IV) Iron Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Intraveno (IV) Iron Drugs include Sanofi, Vifor Pharma, Pharmacosmos, Luitpold Pharmaceuticals, Galenica, Fresenius Medical Care, American Regent, AMAG Pharmaceuticals and Allergan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Intraveno (IV) Iron Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Intraveno (IV) Iron Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Intraveno (IV) Iron Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Intraveno (IV) Iron Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Intraveno (IV) Iron Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Intraveno (IV) Iron Drugs Market by Company

Sanofi

Vifor Pharma

Pharmacosmos

Luitpold Pharmaceuticals

Galenica

Fresenius Medical Care

American Regent

AMAG Pharmaceuticals

Allergan

Actavis

Intraveno (IV) Iron Drugs Segment by Type

Low Molecular Weight Iron Dextran

Ferric Gluconate

Ferric Carboxyl Maltose

Iron Sucrose

Intraveno (IV) Iron Drugs Segment by Application

Ambulatory Surgical Centers

Hospitals

Diagnostic Centers

Intraveno (IV) Iron Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intraveno (IV) Iron Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Intraveno (IV) Iron Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intraveno (IV) Iron Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Intraveno (IV) Iron Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Intraveno (IV) Iron Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Low Molecular Weight Iron Dextran Table 2. Major Company of Ferric Gluconate Table 3. Major Company of Ferric Carboxyl Maltose Table 4. Major Company of Iron Sucrose Table 5. Global Intraveno (IV) Iron Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Intraveno (IV) Iron Drugs Sales by Type (2021-2026) & (K Units) Table 7. Global Intraveno (IV) Iron Drugs Sales Market Share in Volume by Type (2021-2026) Table 8. Global Intraveno (IV) Iron Drugs Sales by Type (2021-2026) & (US$ Million) Table 9. Global Intraveno (IV) Iron Drugs Sales Market Share in Value by Type (2021-2026) Table 10. Global Intraveno (IV) Iron Drugs Price by Type (2021-2026) & (US$/Unit) Table 11. Global Intraveno (IV) Iron Drugs Sales by Type (2027-2032) & (K Units) Table 12. Global Intraveno (IV) Iron Drugs Sales Market Share in Volume by Type (2027-2032) Table 13. Global Intraveno (IV) Iron Drugs Sales by Type (2027-2032) & (US$ Million) Table 14. Global Intraveno (IV) Iron Drugs Sales Market Share in Value by Type (2027-2032) Table 15. Global Intraveno (IV) Iron Drugs Price by Type (2027-2032) & (US$/Unit) Table 16. North America Intraveno (IV) Iron Drugs Sales by Type (2021-2026) & (K Units) Table 17. North America Intraveno (IV) Iron Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Intraveno (IV) Iron Drugs Sales by Type (2021-2026) & (K Units) Table 19. Europe Intraveno (IV) Iron Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Intraveno (IV) Iron Drugs Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Intraveno (IV) Iron Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Intraveno (IV) Iron Drugs Sales by Type (2021-2026) & (K Units) Table 23. Latin America Intraveno (IV) Iron Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Intraveno (IV) Iron Drugs Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Intraveno (IV) Iron Drugs Sales by Type (2021-2026) & (US$ Million) Table 26. Intraveno (IV) Iron Drugs Industry Trends Table 27. Intraveno (IV) Iron Drugs Industry Drivers Table 28. Intraveno (IV) Iron Drugs Industry Opportunities and Challenges Table 29. Intraveno (IV) Iron Drugs Industry Restraints Table 30. Global Intraveno (IV) Iron Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Intraveno (IV) Iron Drugs Revenue Market Share by Company (2021-2026) Table 32. Global Intraveno (IV) Iron Drugs Sales by Company (2021-2026) & (K Units) Table 33. Global Intraveno (IV) Iron Drugs Sales Share by Company (2021-2026) Table 34. Global Intraveno (IV) Iron Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Intraveno (IV) Iron Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Intraveno (IV) Iron Drugs Major Company Production Sites and Headquarters Table 37. Global Intraveno (IV) Iron Drugs Company, Product Type & Application Table 38. Global Intraveno (IV) Iron Drugs Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Intraveno (IV) Iron Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Intraveno (IV) Iron Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Intraveno (IV) Iron Drugs Sales by Region (2021-2026) & (K Units) Table 43. Global Intraveno (IV) Iron Drugs Sales Market Share in Volume by Region (2021-2026) Table 44. Global Intraveno (IV) Iron Drugs Sales by Region (2021-2026) & (US$ Million) Table 45. Global Intraveno (IV) Iron Drugs Sales Market Share in Value by Region (2021-2026) Table 46. Global Intraveno (IV) Iron Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Intraveno (IV) Iron Drugs Sales by Region (2027-2032) & (K Units) Table 48. Global Intraveno (IV) Iron Drugs Sales Market Share in Volume by Region (2027-2032) Table 49. Global Intraveno (IV) Iron Drugs Sales by Region (2027-2032) & (US$ Million) Table 50. Global Intraveno (IV) Iron Drugs Sales Market Share in Value by Region (2027-2032) Table 51. Global Intraveno (IV) Iron Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Intraveno (IV) Iron Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Intraveno (IV) Iron Drugs Sales by Application (2021-2026) & (K Units) Table 54. Global Intraveno (IV) Iron Drugs Sales Market Share in Volume by Application (2021-2026) Table 55. Global Intraveno (IV) Iron Drugs Sales by Application (2021-2026) & (US$ Million) Table 56. Global Intraveno (IV) Iron Drugs Sales Market Share in Value by Application (2021-2026) Table 57. Global Intraveno (IV) Iron Drugs Price by Application (2021-2026) & (US$/Unit) Table 58. Global Intraveno (IV) Iron Drugs Sales by Application (2027-2032) & (K Units) Table 59. Global Intraveno (IV) Iron Drugs Sales Market Share in Volume by Application (2027-2032) Table 60. Global Intraveno (IV) Iron Drugs Sales by Application (2027-2032) & (US$ Million) Table 61. Global Intraveno (IV) Iron Drugs Sales Market Share in Value by Application (2027-2032) Table 62. Global Intraveno (IV) Iron Drugs Price by Application (2027-2032) & (US$/Unit) Table 63. North America Intraveno (IV) Iron Drugs Sales by Application (2021-2026) & (K Units) Table 64. North America Intraveno (IV) Iron Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Intraveno (IV) Iron Drugs Sales by Application (2021-2026) & (K Units) Table 66. Europe Intraveno (IV) Iron Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Intraveno (IV) Iron Drugs Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Intraveno (IV) Iron Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Intraveno (IV) Iron Drugs Sales by Application (2021-2026) & (K Units) Table 70. Latin America Intraveno (IV) Iron Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Intraveno (IV) Iron Drugs Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Intraveno (IV) Iron Drugs Sales by Application (2021-2026) & (US$ Million) Table 73. Sanofi Company Information Table 74. Sanofi Business Overview Table 75. Sanofi Intraveno (IV) Iron Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Sanofi Intraveno (IV) Iron Drugs Product Portfolio Table 77. Sanofi Recent Development Table 78. Vifor Pharma Company Information Table 79. Vifor Pharma Business Overview Table 80. Vifor Pharma Intraveno (IV) Iron Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Vifor Pharma Intraveno (IV) Iron Drugs Product Portfolio Table 82. Vifor Pharma Recent Development Table 83. Pharmacosmos Company Information Table 84. Pharmacosmos Business Overview Table 85. Pharmacosmos Intraveno (IV) Iron Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Pharmacosmos Intraveno (IV) Iron Drugs Product Portfolio Table 87. Pharmacosmos Recent Development Table 88. Luitpold Pharmaceuticals Company Information Table 89. Luitpold Pharmaceuticals Business Overview Table 90. Luitpold Pharmaceuticals Intraveno (IV) Iron Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Luitpold Pharmaceuticals Intraveno (IV) Iron Drugs Product Portfolio Table 92. Luitpold Pharmaceuticals Recent Development Table 93. Galenica Company Information Table 94. Galenica Business Overview Table 95. Galenica Intraveno (IV) Iron Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Galenica Intraveno (IV) Iron Drugs Product Portfolio Table 97. Galenica Recent Development Table 98. Fresenius Medical Care Company Information Table 99. Fresenius Medical Care Business Overview Table 100. Fresenius Medical Care Intraveno (IV) Iron Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Fresenius Medical Care Intraveno (IV) Iron Drugs Product Portfolio Table 102. Fresenius Medical Care Recent Development Table 103. American Regent Company Information Table 104. American Regent Business Overview Table 105. American Regent Intraveno (IV) Iron Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. American Regent Intraveno (IV) Iron Drugs Product Portfolio Table 107. American Regent Recent Development Table 108. AMAG Pharmaceuticals Company Information Table 109. AMAG Pharmaceuticals Business Overview Table 110. AMAG Pharmaceuticals Intraveno (IV) Iron Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. AMAG Pharmaceuticals Intraveno (IV) Iron Drugs Product Portfolio Table 112. AMAG Pharmaceuticals Recent Development Table 113. Allergan Company Information Table 114. Allergan Business Overview Table 115. Allergan Intraveno (IV) Iron Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Allergan Intraveno (IV) Iron Drugs Product Portfolio Table 117. Allergan Recent Development Table 118. Actavis Company Information Table 119. Actavis Business Overview Table 120. Actavis Intraveno (IV) Iron Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Actavis Intraveno (IV) Iron Drugs Product Portfolio Table 122. Actavis Recent Development Table 123. North America Intraveno (IV) Iron Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 124. North America Intraveno (IV) Iron Drugs Sales by Country (2021-2026) & (K Units) Table 125. North America Intraveno (IV) Iron Drugs Sales Market Share by Country (2021-2026) Table 126. North America Intraveno (IV) Iron Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 127. North America Intraveno (IV) Iron Drugs Sales Market Share Forecast by Country (2027-2032) Table 128. North America Intraveno (IV) Iron Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. North America Intraveno (IV) Iron Drugs Market Size by Country (2021-2026) & (US$ Million) Table 130. North America Intraveno (IV) Iron Drugs Market Share by Country (2021-2026) Table 131. North America Intraveno (IV) Iron Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. North America Intraveno (IV) Iron Drugs Market Share Forecast by Country (2027-2032) Table 133. Europe Intraveno (IV) Iron Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 134. Europe Intraveno (IV) Iron Drugs Sales by Country (2021-2026) & (K Units) Table 135. Europe Intraveno (IV) Iron Drugs Sales Market Share by Country (2021-2026) Table 136. Europe Intraveno (IV) Iron Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 137. Europe Intraveno (IV) Iron Drugs Sales Market Share Forecast by Country (2027-2032) Table 138. Europe Intraveno (IV) Iron Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Europe Intraveno (IV) Iron Drugs Market Size by Country (2021-2026) & (US$ Million) Table 140. Europe Intraveno (IV) Iron Drugs Market Share by Country (2021-2026) Table 141. Europe Intraveno (IV) Iron Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Europe Intraveno (IV) Iron Drugs Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Intraveno (IV) Iron Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Intraveno (IV) Iron Drugs Sales by Country (2021-2026) & (K Units) Table 145. Asia-Pacific Intraveno (IV) Iron Drugs Sales Market Share by Country (2021-2026) Table 146. Asia-Pacific Intraveno (IV) Iron Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 147. Asia-Pacific Intraveno (IV) Iron Drugs Sales Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Intraveno (IV) Iron Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Intraveno (IV) Iron Drugs Market Size by Country (2021-2026) & (US$ Million) Table 150. Asia-Pacific Intraveno (IV) Iron Drugs Market Share by Country (2021-2026) Table 151. Asia-Pacific Intraveno (IV) Iron Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Asia-Pacific Intraveno (IV) Iron Drugs Market Share Forecast by Country (2027-2032) Table 153. Latin America Intraveno (IV) Iron Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 154. Latin America Intraveno (IV) Iron Drugs Sales by Country (2021-2026) & (K Units) Table 155. Latin America Intraveno (IV) Iron Drugs Sales Market Share by Country (2021-2026) Table 156. Latin America Intraveno (IV) Iron Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 157. Latin America Intraveno (IV) Iron Drugs Sales Market Share Forecast by Country (2027-2032) Table 158. Latin America Intraveno (IV) Iron Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Latin America Intraveno (IV) Iron Drugs Market Size by Country (2021-2026) & (US$ Million) Table 160. Latin America Intraveno (IV) Iron Drugs Market Share by Country (2021-2026) Table 161. Latin America Intraveno (IV) Iron Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Latin America Intraveno (IV) Iron Drugs Market Share Forecast by Country (2027-2032) Table 163. Middle East and Africa Intraveno (IV) Iron Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 164. Middle East and Africa Intraveno (IV) Iron Drugs Sales by Country (2021-2026) & (K Units) Table 165. Middle East and Africa Intraveno (IV) Iron Drugs Sales Market Share by Country (2021-2026) Table 166. Middle East and Africa Intraveno (IV) Iron Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 167. Middle East and Africa Intraveno (IV) Iron Drugs Sales Market Share Forecast by Country (2027-2032) Table 168. Middle East and Africa Intraveno (IV) Iron Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Middle East and Africa Intraveno (IV) Iron Drugs Market Size by Country (2021-2026) & (US$ Million) Table 170. Middle East and Africa Intraveno (IV) Iron Drugs Market Share by Country (2021-2026) Table 171. Middle East and Africa Intraveno (IV) Iron Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Middle East and Africa Intraveno (IV) Iron Drugs Market Share Forecast by Country (2027-2032) Table 173. Key Raw Materials Table 174. Raw Materials Key Suppliers Table 175. Intraveno (IV) Iron Drugs Distributors List Table 176. Intraveno (IV) Iron Drugs Customers List Table 177. Research Programs/Design for This Report Table 178. Authors List of This Report Table 179. Secondary Sources Table 180. Primary Sources List of Figures Figure 1. Intraveno (IV) Iron Drugs Image Figure 2. Global Intraveno (IV) Iron Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Intraveno (IV) Iron Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Intraveno (IV) Iron Drugs Sales (2021-2032) & (K Units) Figure 5. Low Molecular Weight Iron Dextran Image Figure 6. Global Low Molecular Weight Iron Dextran Sales YoY Growth (2021-2032) & (K Units) Figure 7. Ferric Gluconate Image Figure 8. Global Ferric Gluconate Sales YoY Growth (2021-2032) & (K Units) Figure 9. Ferric Carboxyl Maltose Image Figure 10. Global Ferric Carboxyl Maltose Sales YoY Growth (2021-2032) & (K Units) Figure 11. Iron Sucrose Image Figure 12. Global Iron Sucrose Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Intraveno (IV) Iron Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Intraveno (IV) Iron Drugs Market Share by Type 2025 VS 2032 Figure 15. North America Intraveno (IV) Iron Drugs Sales Market Share in Volume by Type in 2025 Figure 16. North America Intraveno (IV) Iron Drugs Sales Market Share in Value by Type in 2025 Figure 17. Europe Intraveno (IV) Iron Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Europe Intraveno (IV) Iron Drugs Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Intraveno (IV) Iron Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Intraveno (IV) Iron Drugs Sales Market Share in Value by Type in 2025 Figure 21. Latin America Intraveno (IV) Iron Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Intraveno (IV) Iron Drugs Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Intraveno (IV) Iron Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Intraveno (IV) Iron Drugs Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Intraveno (IV) Iron Drugs Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Ambulatory Surgical Centers Image Figure 28. Global Ambulatory Surgical Centers Sales YoY Growth (2021-2032) & (K Units) Figure 29. Hospitals Image Figure 30. Global Hospitals Sales YoY Growth (2021-2032) & (K Units) Figure 31. Diagnostic Centers Image Figure 32. Global Diagnostic Centers Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Intraveno (IV) Iron Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Intraveno (IV) Iron Drugs Market Share by Application 2025 VS 2032 Figure 35. North America Intraveno (IV) Iron Drugs Sales Market Share in Volume by Application in 2025 Figure 36. North America Intraveno (IV) Iron Drugs Sales Market Share in Value by Application in 2025 Figure 37. Europe Intraveno (IV) Iron Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Europe Intraveno (IV) Iron Drugs Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Intraveno (IV) Iron Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Intraveno (IV) Iron Drugs Sales Market Share in Value by Application in 2025 Figure 41. Latin America Intraveno (IV) Iron Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Intraveno (IV) Iron Drugs Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Intraveno (IV) Iron Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Intraveno (IV) Iron Drugs Sales Market Share in Value by Application in 2025 Figure 45. North America Intraveno (IV) Iron Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Intraveno (IV) Iron Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Intraveno (IV) Iron Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Intraveno (IV) Iron Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Intraveno (IV) Iron Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Intraveno (IV) Iron Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Intraveno (IV) Iron Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Intraveno (IV) Iron Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Intraveno (IV) Iron Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Intraveno (IV) Iron Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Intraveno (IV) Iron Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Intraveno (IV) Iron Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Intraveno (IV) Iron Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Intraveno (IV) Iron Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Intraveno (IV) Iron Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Intraveno (IV) Iron Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Intraveno (IV) Iron Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Intraveno (IV) Iron Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Intraveno (IV) Iron Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Intraveno (IV) Iron Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Intraveno (IV) Iron Drugs Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Intraveno (IV) Iron Drugs Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Low Molecular Weight Iron Dextran
  • Ferric Gluconate
  • Ferric Carboxyl Maltose
  • Iron Sucrose
Applications
  • Ambulatory Surgical Centers
  • Hospitals
  • Diagnostic Centers
Companies covered
  • Sanofi
  • Vifor Pharma
  • Pharmacosmos
  • Luitpold Pharmaceuticals
  • Galenica
  • Fresenius Medical Care
  • American Regent
  • AMAG Pharmaceuticals
  • Allergan
  • Actavis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Intraveno (IV) Iron Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Intraveno (IV) Iron Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Intraveno (IV) Iron Drugs Market by Type
  6. 1.3.1 Low Molecular Weight Iron Dextran
  7. 1.3.2 Ferric Gluconate
  8. 1.3.3 Ferric Carboxyl Maltose
  9. 1.3.4 Iron Sucrose
  10. 1.4 Global Intraveno (IV) Iron Drugs Market Size by Type
  11. 1.4.1 Global Intraveno (IV) Iron Drugs Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Intraveno (IV) Iron Drugs Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Intraveno (IV) Iron Drugs Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Intraveno (IV) Iron Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Intraveno (IV) Iron Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Intraveno (IV) Iron Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Intraveno (IV) Iron Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Intraveno (IV) Iron Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Intraveno (IV) Iron Drugs Industry Trends
  2. 2.2 Intraveno (IV) Iron Drugs Industry Drivers
  3. 2.3 Intraveno (IV) Iron Drugs Industry Opportunities and Challenges
  4. 2.4 Intraveno (IV) Iron Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Intraveno (IV) Iron Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Intraveno (IV) Iron Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Intraveno (IV) Iron Drugs Price (2021-2026)
  4. 3.4 Global Intraveno (IV) Iron Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Intraveno (IV) Iron Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Intraveno (IV) Iron Drugs Company, Product Type & Application
  7. 3.7 Global Intraveno (IV) Iron Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Intraveno (IV) Iron Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Intraveno (IV) Iron Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Intraveno (IV) Iron Drugs Tier 1, Tier 2, and Tier 3
4 Intraveno (IV) Iron Drugs Regional Status and Outlook
  1. 4.1 Global Intraveno (IV) Iron Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Intraveno (IV) Iron Drugs Historic Market Size by Region
  3. 4.2.1 Global Intraveno (IV) Iron Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Intraveno (IV) Iron Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Intraveno (IV) Iron Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Intraveno (IV) Iron Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Intraveno (IV) Iron Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Intraveno (IV) Iron Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Intraveno (IV) Iron Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Intraveno (IV) Iron Drugs by Application
  1. 5.1 Intraveno (IV) Iron Drugs Market by Application
  2. 5.1.1 Ambulatory Surgical Centers
  3. 5.1.2 Hospitals
  4. 5.1.3 Diagnostic Centers
  5. 5.2 Global Intraveno (IV) Iron Drugs Market Size by Application
  6. 5.2.1 Global Intraveno (IV) Iron Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Intraveno (IV) Iron Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Intraveno (IV) Iron Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Intraveno (IV) Iron Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Intraveno (IV) Iron Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Intraveno (IV) Iron Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Intraveno (IV) Iron Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Intraveno (IV) Iron Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Intraveno (IV) Iron Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Intraveno (IV) Iron Drugs Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Vifor Pharma
  8. 6.2.1 Vifor Pharma Company Information
  9. 6.2.2 Vifor Pharma Business Overview
  10. 6.2.3 Vifor Pharma Intraveno (IV) Iron Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Vifor Pharma Intraveno (IV) Iron Drugs Product Portfolio
  12. 6.2.5 Vifor Pharma Recent Developments
  13. 6.3 Pharmacosmos
  14. 6.3.1 Pharmacosmos Company Information
  15. 6.3.2 Pharmacosmos Business Overview
  16. 6.3.3 Pharmacosmos Intraveno (IV) Iron Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pharmacosmos Intraveno (IV) Iron Drugs Product Portfolio
  18. 6.3.5 Pharmacosmos Recent Developments
  19. 6.4 Luitpold Pharmaceuticals
  20. 6.4.1 Luitpold Pharmaceuticals Company Information
  21. 6.4.2 Luitpold Pharmaceuticals Business Overview
  22. 6.4.3 Luitpold Pharmaceuticals Intraveno (IV) Iron Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Luitpold Pharmaceuticals Intraveno (IV) Iron Drugs Product Portfolio
  24. 6.4.5 Luitpold Pharmaceuticals Recent Developments
  25. 6.5 Galenica
  26. 6.5.1 Galenica Company Information
  27. 6.5.2 Galenica Business Overview
  28. 6.5.3 Galenica Intraveno (IV) Iron Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Galenica Intraveno (IV) Iron Drugs Product Portfolio
  30. 6.5.5 Galenica Recent Developments
  31. 6.6 Fresenius Medical Care
  32. 6.6.1 Fresenius Medical Care Company Information
  33. 6.6.2 Fresenius Medical Care Business Overview
  34. 6.6.3 Fresenius Medical Care Intraveno (IV) Iron Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Fresenius Medical Care Intraveno (IV) Iron Drugs Product Portfolio
  36. 6.6.5 Fresenius Medical Care Recent Developments
  37. 6.7 American Regent
  38. 6.7.1 American Regent Company Information
  39. 6.7.2 American Regent Business Overview
  40. 6.7.3 American Regent Intraveno (IV) Iron Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 American Regent Intraveno (IV) Iron Drugs Product Portfolio
  42. 6.7.5 American Regent Recent Developments
  43. 6.8 AMAG Pharmaceuticals
  44. 6.8.1 AMAG Pharmaceuticals Company Information
  45. 6.8.2 AMAG Pharmaceuticals Business Overview
  46. 6.8.3 AMAG Pharmaceuticals Intraveno (IV) Iron Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 AMAG Pharmaceuticals Intraveno (IV) Iron Drugs Product Portfolio
  48. 6.8.5 AMAG Pharmaceuticals Recent Developments
  49. 6.9 Allergan
  50. 6.9.1 Allergan Company Information
  51. 6.9.2 Allergan Business Overview
  52. 6.9.3 Allergan Intraveno (IV) Iron Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Allergan Intraveno (IV) Iron Drugs Product Portfolio
  54. 6.9.5 Allergan Recent Developments
  55. 6.10 Actavis
  56. 6.10.1 Actavis Company Information
  57. 6.10.2 Actavis Business Overview
  58. 6.10.3 Actavis Intraveno (IV) Iron Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Actavis Intraveno (IV) Iron Drugs Product Portfolio
  60. 6.10.5 Actavis Recent Developments
7 North America by Country
  1. 7.1 North America Intraveno (IV) Iron Drugs Sales by Country
  2. 7.1.1 North America Intraveno (IV) Iron Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Intraveno (IV) Iron Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Intraveno (IV) Iron Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Intraveno (IV) Iron Drugs Market Size by Country
  6. 7.2.1 North America Intraveno (IV) Iron Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Intraveno (IV) Iron Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Intraveno (IV) Iron Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Intraveno (IV) Iron Drugs Sales by Country
  2. 8.1.1 Europe Intraveno (IV) Iron Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Intraveno (IV) Iron Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Intraveno (IV) Iron Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Intraveno (IV) Iron Drugs Market Size by Country
  6. 8.2.1 Europe Intraveno (IV) Iron Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Intraveno (IV) Iron Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Intraveno (IV) Iron Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Intraveno (IV) Iron Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Intraveno (IV) Iron Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Intraveno (IV) Iron Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Intraveno (IV) Iron Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Intraveno (IV) Iron Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Intraveno (IV) Iron Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Intraveno (IV) Iron Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Intraveno (IV) Iron Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Intraveno (IV) Iron Drugs Sales by Country
  2. 10.1.1 South America Intraveno (IV) Iron Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Intraveno (IV) Iron Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Intraveno (IV) Iron Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Intraveno (IV) Iron Drugs Market Size by Country
  6. 10.2.1 South America Intraveno (IV) Iron Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Intraveno (IV) Iron Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Intraveno (IV) Iron Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Intraveno (IV) Iron Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Intraveno (IV) Iron Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Intraveno (IV) Iron Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Intraveno (IV) Iron Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Intraveno (IV) Iron Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Intraveno (IV) Iron Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Intraveno (IV) Iron Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Intraveno (IV) Iron Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Intraveno (IV) Iron Drugs Value Chain Analysis
  2. 12.1.1 Intraveno (IV) Iron Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Intraveno (IV) Iron Drugs Production Mode & Process
  7. 12.2 Intraveno (IV) Iron Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Intraveno (IV) Iron Drugs Distributors
  10. 12.2.3 Intraveno (IV) Iron Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst